Research Surveys


Systems-Based Hospital Practices of Acute TBI

Traumatic brain injury (TBI) is a significant cause of morbidity and mortality, afflicting all ages, socioeconomic classes and racial backgrounds. TBI is also one of the most common admitting diagnosis to a neuroscience intensive care unit (ICU). Despite having shared pathophysiology and diagnostic and management principles with other acute neurological disorders, the neurointensivist’s role in the management of TBI has not been clearly established.

Target Audience: All physicians
Duration: 5 minutes
Contact: Roy Poblete


Early Post-traumatic Seizure Prophylaxis: A Worldwide Survey on Current Practice

TBI accounts for about 1.4 million emergency room visits, 275,000 hospital admissions, and 52,000 deaths each year in the US. The reported prevalence of post-traumatic seizures (PTS) following TBI varies; rates of clinical PTS are around 12%, however, subclinical seizures detected on electroencephalogram may be as high as 20-25%. The development of seizures following TBI can be debilitating to patients, complicates management, and increases associated healthcare costs, leading to the rationale for PTS prophylaxis in severe TBI. Both the 2016 Guidelines for the Management of Severe traumatic Brain Injury and the American Academy of Neurology recommend phenytoin to decrease the incidence of early PTS. Current guidelines state available studies are insufficient to support a recommendation for or against the use of levetiracetam for PTS prophylaxis. Phenytoin usage requires routine monitoring of serum drug levels to maintain levels within a narrow therapeutic window. Phenytoin also has a well-understood side effect profile and the potential for significant drug interactions. In the past decade, several studies have been conducted comparing the effectiveness of phenytoin with levetiracetam for PTS prophylaxis, as an alternative agent that lacks the major disadvantages of phenytoin (more favorable side effect profile and no need for routine drug level monitoring). Previous levetiracetam studies lacked standardized protocols so there is uncertainty regarding the best dosing strategy and utilization of this therapy. A worldwide survey to characterize current clinical practice regarding the utilization of early PTS prophylaxis could be very helpful in standardizing therapy and designing future research.

Target Audience
: All NCS members
Duration: 8 minutes
Contact: Gretchen Brophy
Survey closes: June 9, 2021


Point-of-Care Ultrasound (POCUS)/Critical Care Ultrasound (CCU)

POCUS/CCU is a non-invasive and low-cost bedside assessment that can provide real-time information in the management of critically-ill patients. Studies have shown that POCUS/CCU can improve diagnostic accuracy in undifferentiated shock, reduce the length of time on mechanical ventilation and the need for conventional diagnostic imaging, and shorten intensive care unit length of stay. The use of POCUS/CCU has been shown to help prevent secondary brain injury due to hemodynamic disruptions that are particularly unique to patients with critical neurological illness. The use of POCUS/CCU in medical and surgical intensive care units has increased tremendously over the last few decades. However, it is unclear if POCUS/CCU use by neurointensivists has similarly translated with the advent of specialized neurocritical care units. Additionally, prior surveys on ultrasound use in critical care units and training have largely queried non-neurointensivists and non-neurocritical care fellowship trainees. The purpose of this survey is to describe the current state of POCUS/CCU use among neurointensivists for management of neurocriticallyill patients in dedicated neurocritical care units throughout the NCS community.

Target Audience
: US-based MDs, APs, Trainees (fellows, residents, medical students)
Duration: 15 minutes
Contact: Judy Ch'ang
Survey closes: June 9, 2021



Name of Survey
Survey Opened
Contact Name

NCS' Assessment of the Advance Practice Provider (APP) Response to COVID-19
September 11, 2020
Lindsay Marchetti

COVID-19 and Telehealth in the Intensive Care Unit Setting
September 11, 2020
Sarah Nelson

Acute Stroke Management of Tandem Occlusions during Mechanical Thrombectomy (MT) Survey
August 23, 2020
Santiago Ortega-Gutierrez

Perceptions of Health Care Providers Worldwide Regarding COVID-19 Pandemic & Its Impact on Patient Care, Resources, and Clinical Education
April 28, 2020
Sarah Wahlster

Practice Changes for Acute Ischemic Stroke During COVID-19
April 16, 2020
Tamara Strohm

Moyamoya Disease Survey of International Perioperative Practices

March 13th, 2020

Carolina B Maciel

Hypotension in the ICU
January 16, 2020
Ward van der Ven

Career Satisfaction
October 7, 2019
Shyam Rao

Sedation Management in Patients with Severe Traumatic Brain Injury Survey
August 13, 2019
Victoria Mcredie

Drug Shortages
July 18, 2019
Emily Durr

Laboratory Values that Preclude Brain Death Diagnosis
July 9, 2019
David Lerner

Determination of the Inter Rater Reliability of the modified Fisher Scale
July 2, 2019
Christopher Melinosky

Pharmacogenomics of Calcium Channel Blocker Medication in Stroke and Subarachnoid Hemorrhage
May 16, 2019
David Freeman


Pending approval from the Research Operations Sub-Committee, NCS Members are allowed the opportunity to post surveys for free-will participation from the NCS Membership. Surveys are reviewed by the Committee on a monthly basis. Following submission of the form you will receive a follow up email from NCS staff regarding whether your survey has been approved.

If you would like to be considered to have your survey to be posted, please review the following requirements:
1. Complete the required Submission Form below.
2. If accepted, complete a Feedback Survey after the survey has closed.

Create your own user feedback survey